Sandra B. Gabelli, Ph.D.

1983-1988 Dept. Mathematics Universidad Nacional del Sur (Argentina) 
 1993- Medicine, Oncology, Biophysics and Biophysical Chemistry Johns Hopkins University School of Medicine, Baltimore, MD, United States 
PI3K, Nudix, Sodium Voltage Gated Channels, FPPS, Immunotherapy, structural biology
"Sandra B. Gabelli"
Mean distance: (not calculated yet)


Sign in to add mentor
L Mario Amzel grad student 2000 Johns Hopkins
 (The structure of the ADP -ribose pyrophosphatase reveals the versatility of the Nudix hydrolases.)
Bert Vogelstein post-doc Johns Hopkins Medical School/HHMI
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Srinivasan L, Alzogaray V, Selvakumar D, et al. (2022) Development of High affinity Nanobodies Specific for Na1.4 and Na1.5 Voltage-Gated Sodium Channel Isoforms. The Journal of Biological Chemistry. 101763
Pearlman AH, Hwang MS, Konig MF, et al. (2022) Author Correction: Targeting public neoantigens for cancer immunotherapy. Nature Cancer. 2: 865-867
Salguero AL, Chen M, Balana AT, et al. (2021) Multifaceted Regulation of Akt by Diverse C-Terminal Post-translational Modifications. Acs Chemical Biology
Ma Q, Srinivasan L, Gabelli SB, et al. (2021) Elusive structure of mammalian DGKs. Advances in Biological Regulation. 100847
Pearlman AH, Hwang MS, Konig MF, et al. (2021) Targeting public neoantigens for cancer immunotherapy. Nature Cancer. 2: 487-497
Dempsey DR, Viennet T, Iwase R, et al. (2021) The structural basis of PTEN regulation by multi-site phosphorylation. Nature Structural & Molecular Biology. 28: 858-868
Hwang MS, Miller MS, Thirawatananond P, et al. (2021) Structural engineering of chimeric antigen receptors targeting HLA-restricted neoantigens. Nature Communications. 12: 5271
Nathan S, Gabelli S. (2021) Naigating the intricacies of cellular machinery. The Journal of Biological Chemistry. 100832
Hwang MS, Mog BJ, Douglass J, et al. (2021) Targeting loss of heterozygosity for cancer-specific immunotherapy. Proceedings of the National Academy of Sciences of the United States of America. 118
Paul S, Pearlman AH, Douglass J, et al. (2021) TCR beta chain-directed bispecific antibodies for the treatment of T-cell cancers. Science Translational Medicine
See more...